Novel serum tumor marker, RCAS1, in pancreatic diseases.
暂无分享,去创建一个
[1] T. Oshikiri,et al. RCAS1 expression as a prognostic factor after curative surgery for extrahepatic bile duct carcinoma , 2002, Annals of Surgical Oncology.
[2] 日本膵臓学会. Classification of pancreatic carcinoma , 2003 .
[3] T. Oshikiri,et al. High expression of tumor‐associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker , 2002, International journal of cancer.
[4] K. Kotoh,et al. RCAS1 expression in immune-mediated liver diseases. , 2002, Journal of clinical gastroenterology.
[5] T. Kazui,et al. A highly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer , 2002, Annals of human biology.
[6] T. Oshikiri,et al. RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer , 2001, British Journal of Cancer.
[7] S. Inoue,et al. EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine–immune interactions , 2001, British Journal of Cancer.
[8] H. Nawata,et al. Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. , 2001, International journal of oncology.
[9] K. Sugimachi,et al. Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma. , 2001, Cancer letters.
[10] Y. Nakanishi,et al. Expression of tumor‐associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma , 2001, Cancer.
[11] K. Ohshima,et al. Expression of human tumor‐associated antigen RCAS1 in Reed‐Sternberg cells in association with Epstein‐Barr virus infection: A potential mechanism of immune evasion , 2001, International journal of cancer.
[12] Hidetoshi Takahashi,et al. RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin. , 2001, Journal of dermatological science.
[13] H. Nawata,et al. Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. , 2001, Blood.
[14] T. Kaku,et al. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium. , 2000, Gynecologic oncology.
[15] M. Nakashima,et al. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1 , 1999, Nature Medicine.
[16] T. Kaku,et al. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] T. Kaku,et al. A novel tumor‐associated antigen expressed in human uterine and ovarian carcinomas , 1996, Cancer.